Skip to main content
RUNBEN BIOTECHNOLOGY CO., LTD. logo

RUNBEN BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603193 ISIN · CNE100006DK5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 269 across all filing types
Latest filing 2023-10-15 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603193

About RUNBEN BIOTECHNOLOGY CO., LTD.

https://www.runben.com/

Runben Biotechnology Co., Ltd. focuses on the research, development, production, and distribution of personal care and household hygiene solutions. The company’s core product portfolio is categorized into mosquito repellents, infant and child care, and essential oil products. Key offerings include electric mosquito repellent liquids, botanical essential oil patches, and specialized skincare items such as moisturizing creams and cleansing products tailored for sensitive skin. Runben prioritizes the integration of biotechnology with natural formulations to ensure product safety and efficacy. By maintaining a strong emphasis on product innovation and quality control, the company serves a broad consumer base through integrated online and offline sales channels, positioning itself as a provider of health-oriented daily necessities for family environments.

Recent filings

Filing Released Lang Actions
润本股份首次公开发行股票主板上市公告书
Capital/Financing Update Classification · 95% confidence The document is titled as a "首次公开发行股票主板上市公告书" which translates to "Initial Public Offering (IPO) Main Board Listing Announcement." It contains detailed information about the company's stock issuance, listing date, shareholding structure, risk factors related to the IPO, legal basis for the listing, and other related disclosures. The document is lengthy (15,000 characters) and provides comprehensive details about the IPO process and stock issuance but does not contain financial statements or quarterly/yearly financial results. It is an official announcement related to the company's capital market activity, specifically the IPO and stock listing. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a regulatory filing or report publication announcement. Therefore, the correct classification is CAP with high confidence.
2023-10-15 Chinese
润本股份公司章程
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for Runben Biotech Co., Ltd., containing chapters on company organization, share issuance, shareholder rights, board and management structure, financial accounting, audit, and shareholder meeting procedures. It includes detailed provisions on shares, shareholder meetings, board responsibilities, and legal compliance. There is no indication that this is an annual report, earnings release, or any financial statement. Instead, it is a governance document outlining the company's internal rules and governance practices. Therefore, the document fits the category of Governance Information (CGR). The document length and detail confirm it is the full governance document, not just an announcement or summary.
2023-10-15 Chinese
润本股份首次公开发行股票并在主板上市发行结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行结果公告" which translates to "Issuance Result Announcement" for the company's initial public offering (IPO) and listing on the main board. It details the issuance price, number of shares issued, subscription statistics, underwriting details, and issuance expenses. The content focuses on the results of the capital raising event rather than the full financing report or detailed financial statements. The document length is 2887 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication of comprehensive financial statements or management discussion and analysis. Therefore, this document is best classified as a Capital/Financing Update (CAP) since it provides an update on the company's fundraising activity and capital structure changes related to the IPO.
2023-10-10 Chinese
润本股份首次公开发行股票并在主板上市招股说明书
Regulatory Filings Classification · 95% confidence The document is titled as a "招股说明书" which translates to "Prospectus" or "IPO Prospectus" for Runben Biotechnology Co., Ltd. It details the initial public offering (IPO) of the company's shares on the Shanghai Stock Exchange main board. The content includes detailed information about the stock issuance, company background, financial data, risk factors, governance, and other disclosures typical of an IPO prospectus. This type of document is neither an annual report, earnings release, nor a regulatory filing in the usual sense, but rather a detailed offering document for a company's initial public offering. Among the provided filing categories, none explicitly mention IPO prospectuses. The closest relevant category is "Regulatory Filings (RNS)" which serves as a fallback for miscellaneous filings that do not fit other categories. Therefore, the document should be classified as Regulatory Filings (RNS) with high confidence due to its nature as a formal regulatory disclosure document for IPO purposes.
2023-10-10 Chinese
润本股份首次公开发行股票并在主板上市招股说明书提示性公告
Regulatory Filings Classification · 95% confidence The document is titled as a "招股说明书提示性公告" which translates to "Prospectus Indicative Announcement" related to the company's initial public offering (IPO) and listing on the main board. It contains details about the IPO such as the number of shares issued, price, underwriting, and regulatory approvals from the China Securities Regulatory Commission and Shanghai Stock Exchange. The document is relatively short (1865 characters) and serves as an announcement of the prospectus and IPO details rather than the full prospectus or financial report itself. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory announcement about the IPO and prospectus disclosure, not a full financial report or detailed prospectus document.
2023-10-10 Chinese
润本股份首次公开发行股票并在主板上市网下初步配售结果及网上中签结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as an announcement regarding the "首次公开发行股票并在主板上市 网下初步配售结果及网上中签结果公告" which translates to "Initial Public Offering (IPO) offline preliminary allotment results and online lottery results announcement". It details the allocation of shares in an IPO, the pricing, the allotment results for offline and online investors, and instructions for payment. It references regulatory approvals from the Shanghai Stock Exchange and the China Securities Regulatory Commission. The document is an announcement of the results of the IPO allotment and subscription, not a financial report or a detailed prospectus. It is a formal disclosure of the allotment and subscription results to investors and the public. This fits the category of Capital/Financing Update (CAP), as it relates to the company's fundraising activity through the IPO and the allocation of shares.
2023-10-08 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.